Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of the Treatment of the Severely Burned With Anabolic Agents on Clinical Outcomes, Recovery and Rehabilitation
NCT00675714Phase 3Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jan 2004
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin, ketoconazole, oxandrolone, propranolol in burn injury, sponsored by The University of Texas Medical Branch at Galveston. Started Jan 2004; status: terminated.
02
Drugs
somatropinketoconazoleoxandrolonepropranolol
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT00675714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00675714.